ArticleClinical trials (London, England)2013

Development of omics-based clinical tests for prognosis and therapy selection: the challenge of achieving statistical robustness and clinical utility.

Lisa M McShane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.